Lelli, G <br/><br/>
The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practice.  [electronic resource] 

 -  Journal of chemotherapy (Florence, Italy)  Jun 2008 
 - 374-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1973-9478 
<br/><br/><label>Standard No.: </label>10.1179/joc.2008.20.3.374  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Camptothecin--administration & dosage<br/>Cetuximab<br/>Colorectal Neoplasms--drug therapy<br/>Disease Progression<br/>Female<br/>Humans<br/>Irinotecan<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Retrospective Studies<br/>Skin--drug effects<br/>Skin Diseases--chemically induced<br/>Weight Loss